These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 14628465)
21. Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target. Wu B; Liu X; Shen J Med Hypotheses; 2008; 71(1):73-6. PubMed ID: 18395354 [TBL] [Abstract][Full Text] [Related]
22. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Renström F; Burén J; Svensson M; Eriksson JW Metabolism; 2007 Feb; 56(2):190-8. PubMed ID: 17224332 [TBL] [Abstract][Full Text] [Related]
23. [Insulin resistance in type 2 diabetes as a microdomain syndrome]. Inokuchi JI; Igarashi Y Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1179-83. PubMed ID: 12807027 [No Abstract] [Full Text] [Related]
29. The mechanism of insulin action. Nakae J; Accili D J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():721-31. PubMed ID: 10626262 [No Abstract] [Full Text] [Related]
30. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion. Sahu A; Metlakunta AS J Neuroendocrinol; 2005 Nov; 17(11):720-6. PubMed ID: 16219000 [TBL] [Abstract][Full Text] [Related]
31. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance. Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442 [TBL] [Abstract][Full Text] [Related]
32. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. Terauchi Y; Takamoto I; Kubota N; Matsui J; Suzuki R; Komeda K; Hara A; Toyoda Y; Miwa I; Aizawa S; Tsutsumi S; Tsubamoto Y; Hashimoto S; Eto K; Nakamura A; Noda M; Tobe K; Aburatani H; Nagai R; Kadowaki T J Clin Invest; 2007 Jan; 117(1):246-57. PubMed ID: 17200721 [TBL] [Abstract][Full Text] [Related]
33. D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work. Larner J IUBMB Life; 2001 Mar; 51(3):139-48. PubMed ID: 11547915 [No Abstract] [Full Text] [Related]
34. [Insulin signalization and molecular mechanisms of insulin resistance]. Kahn CR Journ Annu Diabetol Hotel Dieu; 1999; ():125-41. PubMed ID: 10732412 [No Abstract] [Full Text] [Related]
35. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Kahn BB Cell; 1998 Mar; 92(5):593-6. PubMed ID: 9506512 [No Abstract] [Full Text] [Related]
36. Insulin receptor structure and function in normal and pathological conditions. Becker AB; Roth RA Annu Rev Med; 1990; 41():99-115. PubMed ID: 2184752 [TBL] [Abstract][Full Text] [Related]
37. [Regulation of insulin signaling and its disorder]. Araki E; Kondo T Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):120-4. PubMed ID: 15855728 [No Abstract] [Full Text] [Related]
38. [Regulation of insulin receptor function in microdomains]. Inokuchi J; Kabayama K; Nagafuku M; Sato T Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1552-7. PubMed ID: 21089365 [No Abstract] [Full Text] [Related]
39. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Zick Y Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S56-60. PubMed ID: 14704747 [TBL] [Abstract][Full Text] [Related]
40. [Insulin action: receptor binding and signal relay]. Hepp D Med Klin; 1980 Apr; 75(8):276-87. PubMed ID: 6248750 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]